UPDATE: SVB Leerink On Bio-Techne Price Target Increase: Firm Continues To View Co. As High-Growth Research Tools Engine With A Consumables-Heavy Business Driving Growth In Key End-Markets Of Preclinical Discovery, Proteomics, Cell Therapy, Liquid Biopsy.